Skip to main content

Table 5 Toxicity profile during treatment

From: Nanoliposomal irinotecan plus fluorouracil and folinic acid as a second-line treatment option in patients with metastatic pancreatic ductal adenocarcinoma: a retrospective cohort study

Adverse event

Any grade, n (%)

Grade 3–4, n (%)

All

50 (98.0)

36 (70.6)

Nausea

22 (43.1)

4 (7.8)

Vomiting

9 (17.6)

0

Diarrhea

12 (23.5)

3 (5.9)

Fatigue

11 (21.6)

2 (3.9)

Neutropenia

43 (84.3)

30 (58.8)

Febrile neutropenia

4 (7.8)

4 (7.8)

Anemia

43 (84.3)

14 (27.5)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us